Lloyd Properties donates 860 acres of Ventura hillsides to land trust
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →iCRco files for bankruptcy following lawsuit
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Caruso breaks ground on Miramar resort not a moment too soon
You might call it “Rick Caruso moment, take two.” A couple of years ago I coined the phrase “Rick Caruso moment” to describe the curious phenomenon on the Central Coast where projects don’t really begin – they just move forward on their own momentum after the last opponents fade away. Such was the case, I Read More →
Read More →Confessions of a Digital Heretic: Nonprofit journalism crashes the paywall
By Henry Dubroff When Pacific Coast Business Times staff writer Alex Kacik won a USC Annenberg School fellowship in health journalism this year, the last thing on my mind what that his project would run head-on into our paywall. But that’s precisely what happened after he wrote the first in a series of stories about Read More →
Read More →Resonant hires new chief financial officer
Resonant, a late stage Goleta development company designing small smartphone technology, said Oct. 12 it named Jeff Killian its new chief financial officer. Killian previously served as the CFO of Oregon-based Cascade Microtech from April 2010 until June 2016,, when Cascade Microtech was acquired. Killian will receive a salary of $275,000 and a signing bonus Read More →
Read More →Amgen sells Colorado facility to AstraZeneca for $64.5 million
Thousand Oaks biotech giant Amgen continued its Colorado exit plans recently as it sold a Longmont, Colo., facility to London-based pharmaceutical and biotech company AstraZeneca for $64.5 million. Amgen built the 692,000-square-foot facility in the 1990s to make ingredients for its blockbuster anti-anemia drug Epogen. The site used large vats to produce lines of cell Read More →
Read More →Invoca’s new CEO former Salesforce.com executive
A Salesforce.com executive is the new CEO of Santa Barbara call intelligence company Invoca, the company announced Oct. 11. Greg Johnson took over at the beginning of October for former CEO Mark Woodward, who stepped aside after 15 months as Invoca CEO because of personal matters. Johnson, formerly a senior vice president of product management Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
